906648-99-5

Basic information

• Product Name: 3-(2-amino-5-methoxy-phenyl)-pentan-3-ol
• Synonyms: 3-(2-amino-5-methoxy-phenyl)-pentan-3-ol
• CAS NO: 906648-99-5
• Molecular Weight: 209.288
• Mol File: 906648-99-5.mol

Chemical Properties

• CAS DataBase Reference: 3-(2-amino-5-methoxy-phenyl)-pentan-3-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-amino-5-methoxy-phenyl)-pentan-3-ol(906648-99-5)
• EPA Substance Registry System: 3-(2-amino-5-methoxy-phenyl)-pentan-3-ol(906648-99-5)

Safety Data

• Hazardous Substances Data: 906648-99-5(Hazardous Substances Data)

Upstream product

• 2475-80-1 methyl 2-amino-5-methoxybenzoate 
• 925-90-6 ethylmagnesium bromide 

Relevant articles and documents

Water-Soluble Hypervalent Iodine(III) Having an I-N Bond. A Reagent for the Synthesis of Indoles

A readily accessible and bench-stable water-soluble hypervalent iodine(III) reagent (phenyliodonio)sulfamate (PISA) with an I-N bond was synthesized, and its structure was characterized by X-ray crystallography. With PISA, various indoles were synthesized via C-H amination of 2-alkenylanilines involving an aryl migration/intramolecular cyclization cascade with excellent regioselectivity in aqueous CH3CN. Notably, using this new method as the key step, not only two drug molecules, indometacin and zidometacin, but also another bioactive molecule, pravadoline, were synthesized.

POWDER FORMULATIONS FOR INHALATION CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS

The present invention relates to powder formulations for inhalation containing enantiomerically pure compounds of general Formula (I) wherein the groups R1, R2 and R3 may have the meanings indicated in the claims and in th

PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES

The present invention relates to new pharmaceutical combinations which contain in addition to one or more, preferably one compound of general formula 1 wherein the groups R1, R2 and R3 may have the meanings given in the cl

ENANTIOMERICALLY PURE BETA AGONISTS, MANUFACTURING AND USE THEREOF

The present invention relates to enantiomerically pure compounds of formula 1 wherein the groups R1, R2, R3, m and Ym? may have the meanings given in the claims and specification, processes for preparing them an

NEW PHARMACEUTICALLY-ACTIVE COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES

The present invention relates to the use of the compounds of general formula 1 wherein the groups R1, R2 and R3 may have the meanings specified in the claims and in the description, for preparing a pharmaceutical compositi